{"schema_version":"secwatch.filing_event.v1","accession":"0000078003-25-000111","form_type":"8-K","ticker":"PFE","cik":"0000078003","company_name":"PFIZER INC","filed_at":"2025-04-29T23:59:59+00:00","discovered_at":"2026-05-14T18:02:51.250887+00:00","generated_at":"2026-05-23T04:26:31.969851+00:00","sec_items":["2.02","2.05","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Pfizer Q1 revenues $13.7B (-8% YoY), adjusted EPS $0.92 (+12%); reaffirms FY2025 guidance","bullets":["Q1 revenues $13.7B, down 8% YoY; reported diluted EPS $0.52 (down 5%), adjusted diluted EPS $0.92 (up 12%).","Reaffirms FY2025 guidance: revenue $61-$64B, adjusted diluted EPS $2.80-$3.00, with no share buybacks anticipated.","Expands cost realignment: additional $1.2B net savings by 2027 (SI&A focus) plus $500M R&D reinvestment by 2026; one-time costs $1.6B and $600M respectively.","Paxlovid revenue fell $1.5B operationally (75% drop); Vyndaqel family grew 33% operationally; Comirnaty up 62% operationally.","Paid $2.4B in cash dividends ($0.43/shr) in Q1; gross leverage below previously stated target; $3.3B remaining buyback authority."],"urls":{"canonical":"https://secwatch.observer/filing/0000078003-25-000111","json":"https://secwatch.observer/filing/0000078003-25-000111.json","markdown":"https://secwatch.observer/filing/0000078003-25-000111.md","text":"https://secwatch.observer/filing/0000078003-25-000111.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/78003/000007800325000111/0000078003-25-000111-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/78003/000007800325000111/pfe-20250429.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T04:26:31.969851+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}